Neurofenix

UK-based Neurofenix is a digital neurological rehabilitation provider that provides treatment using both telemedicine and sensors. The company’s rehabilitation program focuses on arm and hand therapy through its NeuroBall platform – a tool created to expedite recovery by getting patients to do increasingly challenging repetitive movements to rebuild strength. The ball-shaped sensor was developed using input from over 300 patients and therapists and is personalized for each patient’s needs.

In June 2024, the company launched a virtual clinic for home-based neurological rehabilitation for patients in Florida. The platform, costing USD 49.99 per month, is designed to help patients with neurological conditions, such as those recovering from a stroke, continue their rehabilitation at home with guidance from virtual therapists. The virtual clinic offers customized rehabilitation plans, tracks patient progress, and provides access to a team of therapists. Key features include interactive therapy exercises, virtual consultations with therapists, and a user-friendly platform tailored to patient needs.

Funding and financials

In August 2022, the company raised USD 7 million in a Series A funding round led by AlbionVC. The funds were set aside to expand the company’s product line and invest in its expansion into the US market. Additionally, the funds were also earmarked to carry out clinical trials in the US.